In a colon cancer mouse model, cordycepin treatment not only led to an increase in the number of dendritic cells (DCs) within the TME but also encouraged DCs to present antigens to CD8+ T cells and CD4+ T cells, enhancing the anti-tumour response. The gene discussed is CD8A; the disease is neoplasm.